Your browser doesn't support javascript.
loading
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.
Björk, Johanna K; Ahonen, Ilmari; Mirtti, Tuomas; Erickson, Andrew; Rannikko, Antti; Bützow, Anna; Nordling, Stig; Lundin, Johan; Lundin, Mikael; Sistonen, Lea; Nees, Matthias; Åkerfelt, Malin.
Afiliação
  • Björk JK; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Ahonen I; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
  • Mirtti T; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland.
  • Erickson A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Rannikko A; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland.
  • Bützow A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Nordling S; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland.
  • Lundin J; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lundin M; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland.
  • Sistonen L; Department of Pathology, Medicum, University of Helsinki, Helsinki, Finland.
  • Nees M; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Åkerfelt M; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Oncotarget ; 9(58): 31200-31213, 2018 Jul 27.
Article em En | MEDLINE | ID: mdl-30131848

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article